WHO ICTRP trial
Efficacy of An Ayurvedic Preparation Raj Nirwan Bati (RNB) on symptomatic…
CTRI/2020/06/025998 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/06/025998 |
|---|---|
| Public title | Efficacy of An Ayurvedic Preparation Raj Nirwan Bati (RNB) on symptomatic COVID-19 Patients |
| Scientific title | To Determine the Efficacy of An Ayurvedic Preparation Raj Nirwan Bati (RNB) on symptomatic COVID-19 Patients: A Double-Blind Randomized Controlled Trial - RNB |
| Primary sponsor | Uttar Pradesh University of Medical Sciences |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere |
| Interventions | Intervention1: Raj Nirwan Bati capsule: 1. Mercury (Para) 2. Sulphur (Gandhak) 3. Gold (Sona) 4. Silver (Chandi) 5. Clamina Perpeta 6. Arsenic Trioxide (Hartal Bhasma) 7. Black pepper (Kaali Mirch) 8. Naag Damanti (Snake Plant) 9. Celery… |
| Registration date | Jun 20, 2020 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: